OrthoPediatrics’ scoliosis system gains FDA clearance

The FDA granted OrthoPediatrics 510(k) clearance to expand its Response Scoliosis system to include neuromuscular implants on March 31.

Advertisement

Three insights:

1. The Response NeuroMuscular system is intended for the treatment of neuromuscular scoliosis in pediatric patients.

2. The device will feature a full set of implants and instruments to facilitate insertion and help treat severe hyperlordosis.

3. A team of pediatric orthopedic surgeons is building upon OrthoPediatrics’ Response Spine system to develop the technology.

More articles on devices:
6 industry layoffs, furloughs for physician leaders to know
Dr. Neal ElAttrache defends orthopedic surgeries performed during COVID-19 crisis
‘The patients are deferred; they’re not going away,’ says Life Spine CEO on coronavirus

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.